PRINCETON, N.J., Aug. 2 /PRNewswire-FirstCall/ -- Barrier Therapeutics, Inc. , a pharmaceutical company developing and commercializing products in the field of dermatology, is scheduled to release financial results for the second quarter of 2006, on Monday, August 7, 2006 at approximately 4:00 p.m. Eastern Time. The Company will sponsor a conference call on August 7th at 5:00 p.m. Eastern Time to provide a company update and discuss the financial results for the quarter. Interested investors can listen to the call live over the Internet on the investor relations section of the Company’s web site located at www.barriertherapeutics.com or by dialing 1- 888-802-7346 (U.S.) or 1-973-582-2785 (International) and using conference ID code: 7628109.
What: Barrier Therapeutics, Inc. Second Quarter 2006 Corporate Update and Financial Results Conference Call When: Monday, August 7th at 5:00 p.m. Eastern Time Where: The investor relations section of the Company’s web site located at www.barriertherapeutics.com How: Live over the Internet - Simply log on to the web at the address above, or dial 1-888-802-7346 (U.S.) or 1-973-582-2785 (International) and use conference ID code: 7628109
Barrier Therapeutics, Inc. is a pharmaceutical company focused on the discovery, development and commercialization of pharmaceutical products in the field of dermatology. Barrier Therapeutics currently markets three pharmaceutical products in the United States: Xolegel(TM) (ketoconazole, USP) Gel, 2%, Vusion(TM) (0.25% miconazole nitrate, 15% zinc oxide, 81.35% white petrolatum) Ointment and Solage(R) (mequinol 2.0%, tretinoin 0.01%) Topical Solution. Barrier has other product candidates in various stages of clinical development for the treatment of onychomycosis, psoriasis, acne, and fungal infections. The Company is headquartered in Princeton, New Jersey and has wholly owned subsidiaries in Geel, Belgium and Ontario, Canada. For more information, please visit the company’s web site at http://www.barriertherapeutics.com
Barrier Therapeutics, Inc.
CONTACT: Anne M. VanLent of Barrier Therapeutics, Inc., +1-609-945-1202;Diane Perry, Noonan Russo, +1-212-845-4239
Web site: http://www.barriertherapeutics.com/
